Related Experiment Video
Updated: Jul 18, 2026

06:48
An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
The metastatic cascade in prostate cancer
Manit Arya1, Simon R Bott, Iqbal S Shergill
1Prostate Cancer Research Centre, University College London, The Institute of Urology, 67 Riding House Street, London W1W 7EJ, UK. manit_arya@hotmail.com
Surgical Oncology
|December 8, 2006
Summary
Prostate cancer metastasis drives mortality. Understanding the metastatic cascade, including cell migration and homing, is key for prognostic grouping and developing new therapies to prevent cancer spread.
Area of Science:
- Oncology
- Cancer Biology
- Pathology
Background:
- Prostate cancer morbidity and mortality are primarily linked to its metastatic spread.
- Metastasis involves a complex cascade of cellular events, including neoangiogenesis and lymphangiogenesis.
- The process includes detachment, migration, vascular/lymphatic entry, and specific homing to distant sites like lymph nodes and bone marrow.
Purpose of the Study:
- To elucidate the critical steps of the prostate cancer metastatic cascade.
- To highlight the clinical importance of understanding metastasis for patient prognostication.
- To emphasize the role of metastatic pathway knowledge in developing novel anti-metastatic therapies.
Main Methods:
- Review and synthesis of existing literature on prostate cancer metastasis.
- Analysis of the sequential steps involved in the metastatic cascade.
- Correlation of metastatic mechanisms with clinical outcomes and therapeutic strategies.
Main Results:
- Identified key stages: neoplastic transformation, neo/lymphangiogenesis, detachment, migration, vascular/lymphatic invasion.
- Highlighted non-random homing of prostate cancer cells to specific sites (lymph nodes, bone marrow).
- Established the clinical relevance of understanding the metastatic cascade for prognostic stratification.
Conclusions:
- Understanding the prostate cancer metastatic cascade is crucial for accurate prognostic grouping.
- Knowledge of these processes is vital for the development of targeted therapies to inhibit metastasis.
- Further research into the metastatic cascade can lead to improved patient outcomes and reduced cancer mortality.
Related Concept Videos
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...

